Combination chemotherapy with mitomycin C, adriamycin and cisplatin (MAP) in advanced adenocarcinoma of the lung: Clinical effect and renal toxicity

M. Fujii, K. Kiura, K. Okabe, H. Toki

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Combination chemotherapy with mitomycin C, adriamycin and cisplatin (MAP) in advanced adenocarcinoma of the lung: Clinical effect and renal toxicity'. Together they form a unique fingerprint.